Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
International Journal of Cancer|February 11, 2014
Activating adaptive cellular mechanisms of resistance following sublethal cytotoxic chemotherapy: implications for diagnostic microdosingGregory T Wurz, Michael W DeGregorioScientific Reports|May 18, 2022
Indeterminacy of cannabis impairment and ∆9-tetrahydrocannabinol (∆9-THC) levels in blood and breathGregory T Wurz, Michael W DeGregorioOncoimmunology|December 18, 2012
L-BLP25 vaccine plus letrozole for breast cancer: Is translation possible?Michael Degregorio, Michael Degregorio, Gregory T Wurz, et al.Journal of Cannabis Research|July 7, 2022
Examining impairment and kinetic patterns associated with recent use of hemp-derived Δ8-tetrahydrocannabinol: case studiesGregory T Wurz, Edward Montoya, Michael W DeGregorioOncology Research|May 5, 2007
Ineffectiveness of American ginseng in the prevention of dimethylbenzanthracene-induced mammary tumors in miceGregory T Wurz, Cristina Marchisano-Karpman, Michael W DeGregorioMaturitas|January 22, 2013
Ospemifene, vulvovaginal atrophy, and breast cancerGregory T Wurz, Lin H Soe, Michael W DeGregorioJournal of AOAC International|February 27, 2024
Complexity of Translating Analytics to Recent Cannabis Use and ImpairmentMichael W DeGregorio, Chiao-Jung Kao, Gregory T WurzCritical Reviews in Oncology/Hematology|July 6, 2002
SERMs: current status and future trendsKarla C Morello, Gregory T Wurz, Michael W DeGregorioClinical Pharmacokinetics|March 22, 2003
Pharmacokinetics of selective estrogen receptor modulatorsKarla C Morello, Gregory T Wurz, Michael W DeGregorioClinical Interventions in Aging|November 25, 2014
Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopauseGregory T Wurz, Chiao-Jung Kao, Michael W DeGregorioPageof 3